Design of highly immunogenic liposomal constructs combining structurally independent B cell and T helper cell peptide epitopes

European Journal of Immunology

Volumn 29, Issue 7, 1999, Pages 2297-2308

  Boeckler, Christophe ^a   Dautel, Dominique ^b   Schelté, Philippe ^a   Frisch, Benoît ^a   Wachsmann, Dominique ^b   Klein, Jean Paul ^b   Schuber, Francis ^a,c  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b INSERM   (France)

^c CNRS   (France)

Author keywords

Antigen; Epitope; Liposome; Peptide; Vaccination

Indexed keywords

EPITOPE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPOSOME; PEPTIDE; PHOSPHATIDYLETHANOLAMINE; TETANUS TOXIN; THIOL;

AMINO TERMINAL SEQUENCE; ANAMNESIS; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CONJUGATION; CONTROL; COVALENT BOND; FEMALE; HELPER CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINE PRODUCTION;

AMINO ACID SEQUENCE; ANIMALS; B-LYMPHOCYTES; DRUG DESIGN; EPITOPES; FEMALE; IMMUNIZATION; IMMUNOGLOBULINS; LIPOSOMES; MALE; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PEPTIDES; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0033042783     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199907)29:07<2297::AID-IMMU2297>3.0.CO;2-5     Document Type: Article

References (58)

1. Beck-Sickinger, A. G. and Jung, G., Epitope mapping: synthetic approaches to the understanding of molecular recognition in the immune response. Pharm. Acta Helv. 1993. 68: 3-20.
2. Carter, J. M., Epitope mapping of a protein using the Geysen (PEPSCAN) procedure. Methods Mol. Biol. 1994. 36: 207-223.
3. Castric, P. A. and Cassels, F. J., Peptide epitope mapping in vaccine development: Introduction. J. Ind. Microbiol. Biotechnol. 1997. 19: 56-57.
4. Watts, C., Capture and processing of exogenous antigens for presentation on MHC molecules. Annu. Rev. Immunol. 1997. 15: 821-850.
5. Arnon, R. and Horwitz, R. J., Synthetic peptides as vaccines. Curr. Opin. Immunol. 1992. 4: 449-453.
6. Arnon, R. and Van Regenmortel, M. H. V., Structural basis of antigenic specificity and design of new vaccines. FASEB J. 1992. 6: 3265-3274.
7. Brown, F., Synthetic peptides and purified antigens as vaccines. Int. J. Technol. Assess. Health Care 1994. 10: 161-166.
8. BenYedidia, T. and Arnon, R., Design of peptide and polypeptide vaccines. Curr. Opin. Biotech. 1997. 8: 442-448.
9. Delves, P. J., Lund, T. and Roitt, I. M., Can epitope-focused vaccines select advantageous immune responses? Mol. Med. Today 1997. 3: 55-60.
10. Langeveld, J. P., Casals, J. I., Osterhaus, A. D., Cortes, E., de Swart, R., Vela, C., Dalsgaard, K., Puijk, W. C., Schaaper, W. M. and Meloen, R. H., First peptide vaccine providing protection against viral infection in the target animal: studies of canine parvovirus in dogs. J. Virol. 1994. 68: 4506-4513.
11. Obeid, O. E., Partidos, C. D., Howard, C. R. and Steward, M. W., Protection against morbillivirus-induced encephalitis by immunization with a rationally designed synthetic peptide vaccine containing B- and T-cell epitopes from the fusion protein of measles virus. J. Virol. 1995. 69: 1420-1428.
12. Jackson, D. C., O'Brien-Simpson, N., Ede, N. J. and Brown, L. E., Free radical induced polymerization of synthetic peptides into polymeric immunogens. Vaccine 1997. 15: 1697-1705.
13. Tam, J. P., Recent advances in multiple antigen peptides. J. Immunol. Methods 1996. 196: 17-32.
14. Barr, I. G. and Mitchell, G. F., ISCOMs (immunostimulating complexes): The first decade. Immunol. Cell Biol. 1996. 74: 8-25.
15. Alving, C. R., Koulchin, V., Glenn, G. M. and Rao, M., Liposomes as carriers of peptide antigens: induction of antibodies and cytotoxic T lymphocytes to conjugated and unconjugated peptides. Immunol. Rev. 1995. 145: 5-31.
16. Gregoriadis, G., Gursel, I., Gursel, M. and Mccormack, B., Liposomes as immunological adjuvants and vaccine carriers. J. Control. Release 1996. 41: 49-56.
17. Frisch, B., Muller, S., Briand, J. P., Van Regenmortel, M. H. and Schuber, F., Parameters affecting the immunogenicity of a liposome-associated synthetic hexapeptide antigen. Eur. J. Immunol. 1991. 21: 185-193.
18. Friede, M., Muller, S., Briand, J. P., Van Regenmortel, M. H. and Schuber, F., Induction of immune response against a short synthetic peptide antigen coupled to small neutral liposomes containing monophosphoryl lipid A. Mol. Immunol. 1993. 30: 539-547.
19. Fernandas, I., Frisch, B., Muller, S. and Schuber, F., Synthetic lipopeptides incorporated in liposomes: In vitro stimulation of the proliferation of murine splenocytes and in vivo induction of an immune response against a peptide antigen. Mol. Immunol. 1997. 34: 569-576.
20. Friede, M., Muller, S., Briand, J. P., Plaue, S., Fernandes, I., Frisch, B., Schuber, F. and Van Regenmortel, M. H., Selective induction of protection against influenza virus infection in mice by a lipid-peptide conjugate delivered in liposomes. Vaccine 1994. 12: 791-797.
21. Goodman-Snitkoff, G., Eisele, L. E., Heimer, E. P., Felix, A. M., Anderson, T. T., Fuerst, T. R. and Mannino, R. J., Defining minimal requirements for antibody production to peptide antigen. Vaccine 1990. 8: 257-262.
22. Brumeanu, T. D., Casares, S., Bot, A., Bot, S. and Bona, C. A., Immunogenicity of a contiguous T-B synthetic epitope of the A/PR/8/34 influenza virus. J. Virol. 1997. 71: 5473-5480.
23. Tam, J. P. and Lu, Y. A., Vaccine engineering: enhancement of immunogenicity of synthetic peptide vaccine related to hepatitis in chemically defined models consisting of T- and B-cell epitopes. Proc. Natl. Acad. Sci. USA 1989. 86: 9084-9088.
24. Wilkinson, K. A., Vordermeier, H., Wilkinson, R. J., Ivanyi, J. and Hudecz, F., Synthesis and in vitro T-cell immunogenicity of conjugates with dual specificity: attachment of epitope peptides of 16 and 38 kDa proteins from Mycobacterium tuberculosis to branched polypeptide. Bioconjug. Chem. 1998. 9: 539-547.
25. Cox, J. H., Ivanyi, J., Young, D. B., Lamb, J. R., Syred, A. D. and Francis, M. J., Orientation of epitopes influences the immunogenicity of synthetic peptide dimers. Eur. J. Immunol. 1988. 18: 2015-2019.
26. Partidos, C., Stanley, C. and Steward, M., The influence of orientation and number of copies of T-cell and B-cell epitopes on the specificity and affinity of antibodies induced by chimeric peptides. Eur. J. Immunol. 1992. 22: 2675-2680.
27. Fernandez, I. M., Snijders, A., Benaissa-Trouw, B. J., Harmsen, M., Snippe, H. and Kraaijeveld, C. A., Influence of epitope polarity and adjuvants on the immunogenicity and efficacy of a synthetic peptide vaccine against Semliki forest virus. J. Virol. 1993. 67: 5843-5848.
28. Rouaix, F., Gras-Masse, H., Mazingue, C., Ridel, P. R., Diesis, E., Marguerite, M., Estaquier, J., Capron, A., Tartar, A. and Auriault, C., Improvement of the T-cell response to a non-immunogenic peptide by its tandem association with a highly efficient T-helper peptide. Immunopharmacology 1994. 28: 137-143.
29. Lairmore, M. D., Di George, A. M., Conrad, S. F., Trevino, A. V., Lal, R. B. and Kaumaya, P. T., Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction. J. Virol. 1995. 69: 6077-6089.
30. Marussig, M., Rénia, L., Motard, A., Miltgen, F., Pétour, P., Chauhan, V., Corradin, G. and Mazier, D., Linear and multiple antigen peptides containing defined T and B epitopes of the Plasmodium yoelii circumsporozoite protein: antibody-mediated protection and boosting by sporozoite infection. Int. Immunol. 1997. 9: 1817-1824.
31. Nardin, E. H., CalvoCalle, J. M., Oliveira, G. A., Clavijo, P., Nussenzweig, R., Simon, R, Zeng, W. and Rose, K., Plasmodium falciparum polyoximes: highly immunogenic synthetic vaccines constructed by chemoselective ligation of repeat B-cell epitopes and a universal T-cell epitope of CS protein. Vaccine 1998. 16: 590-600.
32. Peterson, E. M., Cheng, X., Zhenhai, Q. and de la Maza, L. M., The effect of orientation within a chimeric peptide on the immunogenicity of Chlamydia trachomatis epitopes. Mol. Immunol. 1996. 35: 335-339.
33. Sarobe, P., Lasarte, J. J., Larrea, E., Golvano, J. J., Prieto, I., Gullon, A., Prieto, J. and Borras-Cuesta, F., Enhancement of peptide immunogenicity by insertion of a cathepsin-B cleavage site between determinants recognized by B-cells and T-cells. Res. Immunol. 1993. 144: 257-262.
34. Shaw, D. M., Stanley, C. M., Partidos, C. D. and Steward, M. W., Influence of the T-helper epitope on the titre and affinity of antibodies to B-cell epitopes after co-immunization. Mol. Immunol. 1993. 30: 961-968.
35. Bessler, W. G., Baier, W., van den Esche, U., Hoffmann, P., Heinevetter, L., Wiesmüller, K.-H. and Jung, G., Bacterial lipopeptides constitute efficient novel immunogens and adjuvants in parenteral and oral immunization. Behring Inst Mitt. 1997. 98: 390-399.
36. Lett, E., Gangloff, S., Zimmermann, M., Wachsmann, D. and Klein, J. P., Immunogenicity of polysaccharides conjugated to peptides containing T- and B-cell epitopes. Infect. Immun. 1994. 62: 785-792.
37. Panina-Bordignon, P., Tan, A., Termijtelen, A., Demotz, S., Corradin, G. and Lanzavecchia, A., Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur. J. Immunol. 1989. 19: 2237-2242.
38. Martin, F. J. and Papahadjopoulos, D., Irreversible coupling of immunoglobulin fragments to preformed vesicles. J. Biol. Chem. 1982. 257: 286-288.
39. Frisch, B., Boeckler, C. and Schuber, F., Synthesis of short polyoxyethylene-based heterobifunctional cross-linking reagents. Application to the coupling of peptides to liposomes. Bioconjug. Chem. 1996. 7: 180-186.
40. Kichler, A., Remy, J. S., Boussif, O., Frisch, B., Boeckler, C., Behr, J. P. and Schuber, F., Efficient gene delivery with neutral complexes of lipospermine and thiol-reactive phospholipids. Biochem. Biophys. Res. Commun. 1995. 209: 444-450.
41. Boeckler, C., Frisch, B. and Schuber, F., Design and synthesis of thiol-reactive lipopeptides. Bioorg. Med. Chem. Lett. 1998. 8: 2055-2058.
42. del Guercio, M. F., Alexander, J., Kubo, R. T., Arrhenius, T., Maewal, A., Appella, E., Hoffman, S. L., Jones, T., Valmori, D., Sakaguchi, K., Grey, H. M. and Sette, A., Potent immunogenic short linear peptide constructs composed of B cell epitopes and Pan DR T Helper Epitopes (PADRE) for antibody responses in vivo. Vaccine 1997. 15: 441-448.
43. Hoffmann, P., Loleit, M., Mittenbuhler, K., Beck, W., Wiesmüller, K.-H., Jung, G. and Bessler, W. G., Induction of an epitope-specific humoral immune response by lipopeptide-hapten conjugates: Enhancement of the anti-melittin response by a synthetic T helper (T-h)-cell epitope. FEMS Immunol. Med. Microbiol. 1997. 17: 225-234.
44. Sarobe, P., Lasarte, J.-J., Golvano, J., Gullón, A., Civeira, M. P., Prieto, J. and Borrás-Cuesta, F., Induction of antibodies against a peptide hapten does not require covalent linkage between the hapten and a class II presentable T helper peptide. Eur. J. Immunol. 1991. 21: 1555-1558.
45. Brons, N. H. C., Blaich, A., Wiesmüller, K.-H., Schneider, F., Jung, G. and Muller, C. P., Hierarchic T-cell help to non-linked B-cell epitopes. Scand. J. Immunol. 1996. 44: 478-484.
46. Garçon, N. M. J. and Six, H. R., Universal Vaccine Carrier: liposomes that provide T-dependent help to weak antigens. J. Immunol. 1991. 146: 3697-3702.
47. Pietrobon, P. J. F., Garçon, N., Lee, C. H. and Six, H. R., Liposomes that provide-dependent help to weak antigens (T-independent antigens). Immunomethods 1994. 4: 236-243.
48. Gregoriadis, G., Wang, Z., Barenholz, Y. and Francis, M. J., Liposome-entrapped T-cell peptide provides help for a co-entrapped B-cell peptide to overcome genetic restriction in mice and induce immunological memory. Immunology 1993. 80: 535-540.
49. Snapper, C. M., Rosas, F. R., Jin, L., Wortham, C., Kehry, M. R. and Mond, J. J., Bacterial lipoproteins may subsitute for cytokines in the humoral immune response to T cell-independent type II antigens. J. Immunol. 1995. 155: 5582-5589.
50. Lanzavecchia, A., Antigen specific interaction between T and B cells. Nature 1985. 314: 537-539.
51. Lanzavecchia, A., Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes. Annu. Rev. Immunol. 1990. 8: 773-793.
52. Friede, M., Van Regenmortel, M. H. and Schuber, F., Lyophilized liposomes as shelf items for the preparation of immunogenic liposome-peptide conjugates. Anal. Biochem. 1993. 211: 117-122.
53. Metzger, J. W., Wiesmüller, K. H. and Jung, G., Synthesis of N alpha-Fmoc protected derivatives of S-(2,3-Dihydroxypropyl)-cysteine and their application in peptide synthesis. Int. J. Pept. Protein Res. 1991. 38: 545-554.
54. Soell, M., Holveck, F., Scholler, M., Wachsmann, R. D. and Klein, J.-P., Binding of Streptococcus mutans SR protein to human monocytes: production of tumor necrosis factor, interleukin 1, and interleukin 6. Infect. Immun. 1994. 62: 1805-1812.
55. Avrameas, S. and Ternynck, T., The cross-linking of proteins with glutaraldehyde and its use for the preparation of immunosorbents. Immunochemistry 1969. 6: 53-57.
56. Rouser, G., Fleischer, J. and Yamamoto, A., Two dimensional thin layer chromatographic separation of plant lipids and determination of phospholipids by phosphorus analysis of spots. Lipids 1970. 5: 494-496.
57. Riddles, P. W., Blakeley, R. L. and Zerner, B., Ellman's reagent: 5,5′-dithoibis(2-nitrobenzoïc acid): a reexamination. Anal. Biochem. 1979. 94: 75-81.
58. Böhlen, P., Stein, S., Dairman, W. and Udenfriend, S., Fluometric assay of proteins in the nanogram range. Arch. Biochem. Biophys. 1973. 155: 213-220.